Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes.

Although it did not reach statistical significance, the neoadjuvant group achieved greater R0 resection (71.4 vs. 56%, p = 0.47) and had fewer surgical complications (9 vs. 16%, p = 0.58).

also in 111,027 other papers